Hims & Hers Health (HIMS) Other Non-Current Liabilities (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Other Non-Current Liabilities came in at $12.9 million in Q1 2026, up 428.65% year-on-year from $2.4 million in Q1 2025, and up 9.93% quarter-over-quarter from $11.7 million in Q4 2025.
Hims & Hers Health (HIMS) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $12.9 million for Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $12.9 million, up 428.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (up 428.65% YoY), and the FY2025 annual result was $11.7 million, changed N/A from the prior year.
- Other Non-Current Liabilities came in at $12.9 million for Q1 2026 at Hims & Hers Health, up from $11.7 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $12.9 million in Q1 2026 to a low of $21000.0 in Q1 2024.
- The 5-year median for Other Non-Current Liabilities is $1.4 million (2025), against an average of $3.2 million.
- Across the five-year window, Other Non-Current Liabilities sank 99.47% in 2024 and jumped 11519.05% in 2025, its largest moves.
- Hims & Hers Health's Other Non-Current Liabilities stood at $35000.0 in 2022, then slumped by 37.14% to $22000.0 in 2023, then changed by 0.0% to $22000.0 in 2024, then surged by 53236.36% to $11.7 million in 2025, then climbed by 9.93% to $12.9 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $12.9 million (Q1 2026), $11.7 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.90 Mn |
| Dec 31, 2025 | 11.73 Mn |
| Sep 30, 2025 | 6.11 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 2.44 Mn |
| Jun 30, 2024 | 22,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Mar 31, 2023 | 3.98 Mn |
| Dec 31, 2022 | 35,000.00 |
| Sep 30, 2022 | 739,000.00 |
| Jun 30, 2022 | 1.51 Mn |
| Mar 31, 2022 | 517,000.00 |
| Dec 31, 2021 | 2.00 Mn |
| Sep 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 25.41 Mn |
| Mar 31, 2021 | 33.37 Mn |
| Dec 31, 2020 | 381,000.00 |